Bi-Specific Fusion Proteins
US-2024101713-A1 · Mar 28, 2024 · US
This page is not indexed by search engines while we improve data quality.
Wickham Thomas patents
Wickham Thomas is listed as an inventor on 26 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wickham Thomas |
| Total patents | 26 |
| First publication | Apr 2, 2015 |
| Latest publication | Mar 28, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Bi-Specific Fusion Proteins
US-2018237540-A1 · Aug 23, 2018 · US
Bi-specific fusion proteins
US-9982060-B2 · May 29, 2018 · US
Compositions and methods for non-invasive imaging
US-9968694-B2 · May 15, 2018 · US
Combination therapy for treating HER2-positive cancers
US-9913901-B2 · Mar 13, 2018 · US
Bi-Specific Fusion Proteins
US-2017335015-A1 · Nov 23, 2017 · US
Combination therapies for treating her2-positive cancers that are resistant to her2-targeted therapies
US-2017258903-A1 · Sep 14, 2017 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2017231911-A1 · Aug 17, 2017 · US
Method of treating myocardial infarction by administering a bi-specific fusion protein
US-9718892-B2 · Aug 1, 2017 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2017189335-A1 · Jul 6, 2017 · US
Recent patents
Latest publications not already listed above.
Compositions and Methods for Non-Invasive Imaging
US-2017112950-A1 · Apr 27, 2017 · US
Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-9610249-B2 · Apr 4, 2017 · US
Combination Therapies for Treating Her2-Positive Cancers that are Resistant to Her2-Targeted Therapies
US-2017080087-A1 · Mar 23, 2017 · US
Combination therapies for treating her2-positive cancers
US-2017022290-A1 · Jan 26, 2017 · US
Compositions and methods for non-invasive imaging
US-9511155-B2 · Dec 6, 2016 · US
Liposomes useful for non-invasive imaging and drug delivery
US-2016303264-A1 · Oct 20, 2016 · US
Combination therapy for treating her2-positive cancers
US-2016250328-A1 · Sep 1, 2016 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2016184227-A1 · Jun 30, 2016 · US
Bi-Specific Fusion Proteins
US-2016168269-A1 · Jun 16, 2016 · US
Methods and compositions for improving outcomes of liposomal chemotherapy
US-2016067182-A1 · Mar 10, 2016 · US
Combination therapies for treating her2-positive cancers that are resistant to her2-targeted therapies
US-2016045596-A1 · Feb 18, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2016038416-A1 · Feb 11, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-2016038417-A1 · Feb 11, 2016 · US
Bi-specific fusion proteins
US-9238080-B2 · Jan 19, 2016 · US
Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
US-9226966-B2 · Jan 5, 2016 · US
Compositions and methods for non-invasive imaging
US-2015093328-A1 · Apr 2, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merrimack Pharmaceuticals Inc | 26 |
| Silver Creek Pharmaceuticals Inc | 1 |
| Nielsen Ulrik | 1 |
| Wickham Thomas | 1 |
| Schoeberl Birgit | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/704 | 19 |
| A61P35/00 | 16 |
| A61K9/127 | 15 |
| A61K9/0019 | 15 |
| A61K9/1271 | 15 |